GMP compliance – Page 27

Stability OOT Result After Packaging Site Change: CAPA Strategy

Addressing OOT and OOS Observations After a Change in Packaging Site The pharmaceutical industry often experiences deviations from expected outcomes in stability studies, particularly when changes such as a new…

Statistical Analysis of Stability Excursion Impact Using MKT Concepts

Understanding the Impact of Stability Excursions through Statistical Analysis In pharmaceutical manufacturing, stability excursions can significantly impact product quality and regulatory compliance. A stability excursion may manifest as unexpected shifts…

How to Perform Batch Impact Assessment for Stability OOS Results

Effective Strategies for Assessing the Impact of OOS Results in Stability Studies In the realm of pharmaceutical manufacturing and quality assurance, the occurrence of Out-of-Specification (OOS) results during stability studies…

How to Trend pH Drift and Assay Loss in Liquid Dosage Forms

Effective Techniques for Monitoring pH Drift and Assay Loss in Liquid Pharmaceutical Dosage Forms In the realm of pharmaceutical manufacturing, maintaining the integrity of liquid dosage forms is vital for…

Stability OOT and OOS During Tech Transfer: Risk-Based Handling

Managing OOT and OOS Results During Tech Transfer: A Risk-Based Approach In the dynamic landscape of pharmaceutical manufacturing, encountering Out of Trend (OOT) and Out of Specification (OOS) results during…

Stability Data Visualization Methods for Regulatory Reviewers

Effective Visualization Methods for Stability Data Analysis in Regulatory Environments In pharmaceutical manufacturing, ensuring the stability of products is crucial for regulatory compliance and product efficacy. However, the challenges associated…

Why Poor Chamber Mapping Can Create Stability OOT Signals

Understanding Poor Chamber Mapping and Its Impact on Stability Out-of-Trend Signals In the pharmaceutical manufacturing landscape, stability studies are vital for ensuring a product’s quality over its intended shelf life.…

How to Present Stability Statistical Analysis in CTD Submissions

Effective Presentation of Stability Statistical Analysis in CTD Submissions In the pharmaceutical industry, presenting stability statistical analysis effectively in the Common Technical Document (CTD) submissions is crucial to meet regulatory…

Stability OOS in Climatic Zone IVb Studies: Practical Response

Practical Responses to Stability OOS in Climatic Zone IVb Studies In pharmaceutical manufacturing, deviations from established stability parameters can pose significant challenges, particularly in Climatic Zone IVb studies where temperature…

Stability Trending for Nitrosamine Formation Risk Over Time

Effective Stability Trending to Mitigate Nitrosamine Formation Risks Over Time Stability trending is a critical component of pharmaceutical quality assurance, particularly in the context of assessing the risk of nitrosamine…

How to Link Stability OOT Findings to APR and PQR Reviews

Understanding How to Connect Stability OOT Findings to APR and PQR Evaluations In the realm of pharmaceutical manufacturing, one of the most critical components in ensuring product quality and compliance…

How to Validate Excel Templates Used for Stability Trend Analysis

Essential Steps to Validate Excel Templates for Stability Trend Analysis In pharmaceutical manufacturing, the accuracy and integrity of stability trend analysis are critical for ensuring product safety and regulatory compliance.…